HYFT — MindWalk Holdings Corp.

Nasdaq · Health Care · Pharmaceuticals · CIK 1715925 · British Columbia, Canada
Last close
$1.63
Market Cap
$76.14M
52W High
$1.97
52W Low
$0.99
ADV30
350,028
Next earnings
2026-03-12
MindWalk Holdings Corp. operates as a bio-native AI company. It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery and development of biologics. The company, through its LensAI platform and HYFT technology, it partners with pharmaceutical and biotechnology companies to drive de-risk drug development and unlock therapeutic possibilities. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Jan 2026 4,158,000 2,464,000 -3,659,000 -3,930,000 22,987,000 14,072,000 8,127,000
Oct 2025 4,124,000 2,662,000 -2,763,000 -3,195,000 26,102,000 16,508,000 8,397,000
Jul 2025 3,161,000 1,527,000 -4,153,000 -2,959,000 40,748,000 4,897,000 20,005,000
Apr 2025 6,981,000 4,460,000 -1,458,000 -2,161,000 44,441,000 10,665,000 20,815,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-11,195,000
Investing CF
$13,197,000
Financing CF
$-18,000
CapEx
$-746,000
Dividends Paid
Buybacks
$-125,000
EPS Diluted TTM
$-0.88
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-138,864,000
Inventory
$490,000
Receivables
$3,009,000
ST Investments
$27,538,000
EBIT TTM
$-13,196,000
Pretax Income TTM
$-13,221,000
Interest Exp TTM
$185,000
Analysts
3

Yahoo Snapshot (yfinance, live)

Total Revenue
$28,084,000
EBITDA
$-10,485,000
Free Cash Flow
$-3,994,750
Enterprise Value
$74,381,496
Total Cash
$14,072,000
Total Debt
$3,524,000
Shares Out
46,711,866
Trailing EPS
$-0.10
Book Value
$0.23
ROE
-58.8%
ROA
-18.9%
Div Yield

Annual Trend (SEC EDGAR, last 3y)

Revenues vs Net Income (last 3y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Apr 2025 24,520,000 -12,196,000 -30,234,000 44,441,000 20,815,000 -6,410,000
Apr 2024 24,518,000 -13,762,000 -26,115,000 59,988,000 24,310,000 -3,184,000
Apr 2023 20,665,000 -25,611,000 -26,560,000 77,813,000 20,010,000 -19,833,000

Peers — same industry

TickerNameMarket CapLastDaily %
PLRX PLIANT THERAPEUTICS, INC. $76.78M $1.24
GANX Gain Therapeutics, Inc. $77.63M $1.82
ACET Adicet Bio, Inc. $77.87M $8.33
RLYB Rallybio Corp $77.88M $14.70
OSTX OS Therapies Inc $77.94M $1.75

News headlines (Yahoo Finance, 1h cache)

The Biology Came First.
2026-05-18 12:34 · Yahoo
MindWalk Holdings Corp (HYFT) Q3 2026 Earnings Call Highlights: Revenue Surge and Strategic Shifts
2026-03-12 21:02 · Yahoo
MindWalk Holdings Corp. Q3 2026 Earnings Call Summary
2026-03-12 16:44 · Yahoo
MindWalk (HYFT) Q3 2026 Earnings Call Transcript
2026-03-12 16:39 · Yahoo
MindWalk Holdings Corp. (HYFT) Reports Q3 Loss, Lags Revenue Estimates
2026-03-12 13:45 · Yahoo
MindWalk Holdings Corp. Reports Q3 Fiscal 2026 Financial Results
2026-03-12 12:31 · Yahoo
Stagwell (STGW) Q4 Earnings and Revenues Top Estimates
2026-03-10 13:00 · Yahoo
MindWalk Announces B Cell Llama™, a Nanobody Discovery Platform Designed for the Bispecific and Cell Therapy Era
2026-03-06 21:01 · Yahoo
MindWalk Holdings Corp. to Report Third Quarter Fiscal Year 2026 Financial Results on March 12, 2026
2026-03-02 13:31 · Yahoo
MindWalk Applies HYFT® Technology to Detect Functional Adjacency Linked to Portfolio Risk in AI-Designed Therapeutics
2026-01-27 05:01 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.